CD4+ lymphocyte adenosine triphosphate--a new marker in sepsis with acute kidney injury?

BMC Nephrol. 2014 Dec 18:15:203. doi: 10.1186/1471-2369-15-203.

Abstract

Background: AKI frequently develops in sepsis patients, significantly decreasing the overall prognosis. There are currently no diagnostic markers available which reliably predict the prognosis of sepsis-associated AKI. Recently, ATP content of CD4+ T cells (ATP_CD4) has been shown to correlate with survival in sepsis. The aim of the study was to determine ATP_CD4 in sepsis-associated AKI.

Methods: Thirty-three patients with sepsis were prospectively analyzed for ATP_CD4 at three different time points. Results were related to survival, renal recovery, and further clinical/laboratory findings.

Results: ATP_CD4 tended to lower in concentration at 48 h after onset of sepsis in those patients with complete renal recovery. There were no differences between patients with no AKI and those with AKI of different severity (AKIN 1-3). Urinary NGAL did not correlate with renal prognosis.

Conclusion: ATP_CD4 may serve as risk predictor in sepsis-associated AKI. Lower concentrations may indicate a higher chance of complete renal recovery in sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / complications
  • Acute Kidney Injury / diagnosis*
  • Acute-Phase Proteins / urine
  • Adenosine Triphosphate / analysis*
  • Aged
  • Aged, 80 and over
  • Biomarkers / analysis
  • CD4-Positive T-Lymphocytes / chemistry*
  • Disease Progression
  • Female
  • Humans
  • Lipocalin-2
  • Lipocalins / urine
  • Male
  • Middle Aged
  • Prognosis
  • Prospective Studies
  • Proto-Oncogene Proteins / urine
  • Sepsis / complications*
  • Sepsis / diagnosis

Substances

  • Acute-Phase Proteins
  • Biomarkers
  • LCN2 protein, human
  • Lipocalin-2
  • Lipocalins
  • Proto-Oncogene Proteins
  • Adenosine Triphosphate